$0.055000
-0.0036-6.14%
At Close: -
15 minutes delayed
eFFECTOR Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of eFFECTOR Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
EFTR | eFFECTOR Therapeutics | -$4.25 | -$2.02 | — | — | $0.00 | — | — | — | 08/06/2024 | Get Alert |
EFTR | eFFECTOR Therapeutics | -$6.00 | -$2.16 | -$2.16 | 0.00% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
EFTR | eFFECTOR Therapeutics | -$5.50 | -$1.65 | -$3.42 | -107.27% | $674.00K | — | $0.00 | — | 03/25/2024 | Get Alert |
EFTR | eFFECTOR Therapeutics | -$5.75 | -$3.00 | -$3.25 | -8.33% | $867.00K | — | $0.00 | — | 11/13/2023 | Get Alert |
EFTR | eFFECTOR Therapeutics | -$4.25 | -$5.00 | -$4.25 | 15.00% | $2.01M | — | $0.00 | — | 08/08/2023 | Get Alert |
EFTR | eFFECTOR Therapeutics | $1.75 | -$3.50 | -$6.00 | -71.43% | $0.00 | — | $0.00 | — | 05/09/2023 | Get Alert |
EFTR | eFFECTOR Therapeutics | $11.00 | -$6.00 | -$5.50 | 8.33% | $311.00K | $660.00K | $674.00K | 2.12% | 03/08/2023 | Get Alert |
EFTR | eFFECTOR Therapeutics | $10.50 | -$5.25 | -$5.75 | -9.52% | $427.00K | $640.00K | $867.00K | 35.47% | 11/07/2022 | Get Alert |
EFTR | eFFECTOR Therapeutics | -$95.75 | -$95.75 | -$4.25 | 95.56% | $692.00K | $520.00K | $2.01M | 286.73% | 08/09/2022 | Get Alert |
EFTR | eFFECTOR Therapeutics | -$113.75 | -$6.00 | $1.75 | 129.17% | $0.00 | $350.00K | $0.00 | -100.00% | 05/10/2022 | Get Alert |
EFTR | eFFECTOR Therapeutics | -$101.25 | -$6.00 | $11.00 | 283.33% | $42.00K | $120.00K | $311.00K | 159.17% | 03/16/2022 | Get Alert |
EFTR | eFFECTOR Therapeutics | -$132.25 | -$6.25 | $10.50 | 268.00% | $574.00K | — | $427.00K | — | 11/08/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-2.16 | $-2.16 | 0.00 % |
Dec 2023 | 2024-03-25 | $-3.42 | $-1.65 | -107.3 % |
Sep 2023 | 2023-11-13 | $-3.25 | $-3.00 | -8.33 % |
Jun 2023 | 2023-08-08 | $-4.25 | $-5.00 | 15.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-08 | $674.00K | $660.00K | 2.12 % |
Sep 2022 | 2022-11-07 | $867.00K | $640.00K | 35.5 % |
Jun 2022 | 2022-08-09 | $2.01M | $520.00K | 286.7 % |
Mar 2022 | 2022-05-10 | $0 | $350.00K | -100.0 % |
eFFECTOR Therapeutics (EFTR) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-2.16, which hit the estimate of $-2.16.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.